International Trade Administration, 1029-1031 [2010-108]

Download as PDF Federal Register / Vol. 75, No. 5 / Friday, January 8, 2010 / Notices Defense Explosives Safety Board). The service of Mr. Bowling on the PRB has come to a close. His appointment was originally announced in the Federal Register of November 15, 2007 (72 FR 64192). William B. Wark (CSB Board Member) continues to serve as the Chair of the PRB, as announced in the Federal Register of November 15, 2007 (72 FR 64192). David Capozzi (Executive Director, United States Access Board) continues to serve as a Member of the PRB, as announced in the Federal Register of December 5, 2008 (73 FR 74138). This notice is published in the Federal Register pursuant to the requirement of 5 U.S.C. 4314(c)(4). Dated: January 4, 2010. Christopher J. Kirkpatrick, Attorney-Advisor. [FR Doc. 2010–104 Filed 1–7–10; 8:45 am] BILLING CODE 6350–01–P DEPARTMENT OF COMMERCE National Oceanic and Atmospheric Administration RIN 0648–XT56 Marine Mammals; File No. 14486 pwalker on DSK8KYBLC1PROD with NOTICES AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce. ACTION: Notice; receipt of application. SUMMARY: Notice is hereby given that the Alaska SeaLife Center (ASLC), 301 Railway Avenue, PO Box 1329, Seward, Alaska 99664–1329 (Dr. Ian Dutton, Responsible Party), has applied in due form for a permit to receive, import, and export marine mammal specimens for scientific research purposes. DATES: Written, telefaxed, or e-mail comments must be received on or before February 8, 2010. ADDRESSES: The application and related documents are available for review by selecting ‘‘Records Open for Public Comment’’ from the Features box on the Applications and Permits for Protected Species (APPS) home page, https:// apps.nmfs.noaa.gov, and then selecting File No. 14486 from the list of available applications. These documents are also available upon written request or by appointment in the following offices: Permits, Conservation and Education Division, Office of Protected Resources, NMFS, 1315 East-West Highway, Room 13705, Silver Spring, MD 20910; phone (301)713–2289; fax (301)713–0376; and VerDate Nov<24>2008 16:14 Jan 07, 2010 Jkt 220001 Alaska Region, NMFS, P.O. Box 21668, Juneau, AK 99802–1668; phone (907)586–7221; fax (907)586–7249. Written comments on this application should be submitted to the Chief, Permits, Conservation and Education Division, at the address listed above. Comments may also be submitted by facsimile to (301)713–0376, or by email to NMFS.Pr1Comments@noaa.gov. Please include the File No. 14486 in the subject line of the email comment. Those individuals requesting a public hearing should submit a written request to the Chief, Permits, Conservation and Education Division at the address listed above. The request should set forth the specific reasons why a hearing on this application would be appropriate. FOR FURTHER INFORMATION CONTACT: Amy Sloan or Jennifer Skidmore, (301)713–2289. SUPPLEMENTARY INFORMATION: The subject permit is requested under the authority of the Marine Mammal Protection Act of 1972, as amended (MMPA; 16 U.S.C. 1361 et seq.), the regulations governing the taking and importing of marine mammals (50 CFR part 216), the Endangered Species Act of 1973, as amended (ESA; 16 U.S.C. 1531 et seq.), the regulations governing the taking, importing, and exporting of endangered and threatened species (50 CFR 222–226), and the Fur Seal Act of 1966, as amended (16 U.S.C. 1151 et seq.). The primary objective of this application is to support multiple ongoing research programs at the ASLC, including studies of population ecology, diet and nutrition, reproductive physiology, toxicology and health of marine mammals. The ASLC requests the annual collection, receipt, import and export of unlimited samples from 4000 individual cetaceans and 5,000 individual pinnipeds under NMFS jurisdiction for continued research on these species. Samples would be collected under existing permits in the countries of origin, would be the product of a legal subsistence hunt, incidental by-catch, routine husbandry/ medical examinations of public display animals in the U.S., or opportunistic carcass collection, or would be samples taken under other permitted research activities. No takes of live animals, direct or indirect, are requested in this application. ASLC requests the permit be issued for five years. In compliance with the National Environmental Policy Act of 1969 (42 U.S.C. 4321 et seq.), an initial determination has been made that the activity proposed is categorically excluded from the requirement to PO 00000 Frm 00004 Fmt 4703 Sfmt 4703 1029 prepare an environmental assessment or environmental impact statement. Concurrent with the publication of this notice in the Federal Register, NMFS is forwarding copies of the application to the Marine Mammal Commission and its Committee of Scientific Advisors. Dated: January 4, 2010. P. Michael Payne, Chief, Permits, Conservation and Education Division, Office of Protected Resources, National Marine Fisheries Service. [FR Doc. 2010–139 Filed 1–7–10; 8:45 am] BILLING CODE 3510–22–S DEPARTMENT OF COMMERCE International Trade Administration Department of Commerce. Notice. AGENCY: ACTION: Mission Statement Medical Trade Mission to India: March 8–13, 2010. Mission Description The United States Department of Commerce, International Trade Administration, U.S. and Foreign Commercial Service is organizing a Medical Trade Mission to New Delhi, Chennai and Mumbai, India, March 8– 13, 2010. The Medical Trade Mission to India will include representatives of U.S. medical/healthcare industry manufacturers (equipment and devices including laboratory, emergency, diagnostic, physiotherapy, and orthopedic equipment, and healthcare information technology) and service providers. The mission will introduce U.S. suppliers to prospective end-users and partners whose needs and capabilities are targeted to each U.S. participant’s business objectives. The delegates will meet with Indian government officials to obtain first-hand information about regulations, policies and procedures and will visit healthcare facilities. The Commercial Service in India (CS India) will organize appointments and briefings in New Delhi, Chennai and Mumbai, India’s major healthcare industry hubs. U.S. participants will have the opportunity to interact with U.S. Embassy and Consulate officials and CS India healthcare specialists to discuss industry developments, opportunities, and marketing strategies. Medical Fair India, one of the largest medical tradeshows in India, coincides in time and location with the last stop of the Trade Mission. Trade Mission participants, therefore, can exhibit at the E:\FR\FM\08JAN1.SGM 08JAN1 1030 Federal Register / Vol. 75, No. 5 / Friday, January 8, 2010 / Notices tradeshow, in the U.S. Pavilion, as part of their program. Companies wishing to exhibit in the U.S. pavilion at the Medical Fair can register through the CS India office to receive a discount. Commercial Setting The Indian healthcare industry is experiencing a rapid transformation and is emerging as a promising market for U.S. suppliers of high-end products. The Indian healthcare market, currently at $35 billion annually, is expected to reach more than $75 billion annually by 2012. The growth in affluence of more than 300 million middle-income consumers is creating demand for higher standards of healthcare. The changing demographic profile and the rise of lifestyle-related diseases have altered the health seeking behavior of the consumer. While private insurance covers only 10% of the populations, coverage is growing at 40% per year. The medical infrastructure in India is insufficient for the population, with demand for hospitals and beds far exceeding supply. The problem is acute in rural India, which accounts for over half of India’s population, while about 80 percent of available hospital beds are located in the urban centers. Both government and private operators have major expansion plans to meet demand and increase quality. Healthcare in India is provided through primary care facilities and secondary and tertiary care hospitals. While the public sector provides primary and secondary care, tertiary care hospitals are owned and managed by both government and private sector. Over the next 5–6 years, 150–200 tertiary hospital projects are expected to be constructed, including hospitals of varying capacities. Most Indian healthcare facilities use imported medical equipment for diagnosis, treatment and surgery with over 35% of the imports coming from the U.S. New Monday, March 8 ............... Tuesday, March 9 .............. pwalker on DSK8KYBLC1PROD with NOTICES Wednesday, March 10 ....... Thursday, March 11 ........... Friday, March 12 ................ VerDate Nov<24>2008 specialty and super-specialty hospitals depend on the import of high-end medical equipment for over 65 percent of their needs, and this sector is growing at a rate of 15 percent annually. Medical tourism is one of the major external drivers of growth in India’s healthcare sector. India treated 450,000 foreign patients in 2007 and the expected increase in this sector is contributing to improved quality controls. India’s National Accreditation Board for Hospitals (NABH) operates accreditation programs for healthcare organizations. Some private hospitals are also applying for certification from international accreditation organizations such as the Joint Commission International (JCI). Accreditation by NABH and JCI has ensured better standards of healthcare in hospitals. Mission Goals The goal of the Medical Trade Mission to India is to (1) familiarize the U.S. companies with the current healthcare situation as well as the developments taking place; (2) introduce U.S. companies to appropriate government officials in India to learn about various regulatory procedures and policies; and (3) introduce companies to potential end-users, representatives and partners. Mission Scenario The first stop on the mission itinerary is New Delhi, the capital. In meetings with representatives of the Ministry of Health, Drug Controller General Office, and Department of Pharmaceuticals, the U.S. mission members will learn about policies, regulations and opportunities in the country’s healthcare industry, such as expansion plans of the Fortis and Max hospital groups. Chennai and Mumbai are the second and third stops of the mission, located in southern and western India respectively. Several corporate hospital chains have their headquarters in these cities. These include the Apollo Group in Chennai, and Wockhard and the Tata Institute of Fundamental Research in Mumbai. The three cities on the mission itinerary are the regional hubs for the Indian medical/healthcare industry. End-users often prefer to be serviced by regional distributors/agents based in these cities, rather than country-wide distributors. In all three cities the delegates will attend U.S. Embassy or Consulate industry briefings and take part in networking events and business matchmaking appointments. Participation in the mission will include the following: • Pre-travel briefings/webinars on subjects including business practices in India and specifics on the medical/ healthcare industry; • Embassy/Consulate briefings on the business climate, political scenario, and medical/healthcare industry in New Delhi, Chennai and Mumbai; • Pre-scheduled meetings with potential partners, distributors, endusers, or local industry contacts in New Delhi, Chennai and Mumbai; • Meetings with Indian Government officials; • Tour of public and private hospitals and interaction with senior hospital staff; • Networking receptions in three cities of the trade mission; • Built-up 9sq meter exhibitor booth * in the U.S. Pavilion at Medical Fair India, Mumbai. (Option two only.) * Contact us for price of booth. Proposed Mission Timetable Mission participants will be encouraged to arrive Saturday, March 6, 2010 to allow time to adjust to their new surroundings before the mission program begins on Monday, March 8. New Delhi Embassy briefing by U.S. Departments of Commerce and State Meetings with Government of India ministries. One-on-one business appointments. Evening: Networking reception. New Delhi/Chennai Industry briefing. One-on-one business appointments. Hospital or other site visit. Check-out of the hotel. Evening flight to Chennai. Chennai Breakfast briefing by the U.S. Commercial Service at hotel. Hospital visit and meeting with senior management, including the procurement executives. One-on-one business appointments. Evening: Networking reception. Chennai/Mumbai One-on-one business appointments. Check-out of the hotel. Afternoon flight to Mumbai. Mumbai 16:14 Jan 07, 2010 Jkt 220001 PO 00000 Frm 00005 Fmt 4703 Sfmt 4703 E:\FR\FM\08JAN1.SGM 08JAN1 Federal Register / Vol. 75, No. 5 / Friday, January 8, 2010 / Notices Saturday, March 13 ............ Breakfast briefing by the U.S. Commercial Service at hotel. One-on-one business appointments or exhibition at Medical Fair India. Evening: Networking reception. Mumbai Hospital chain visit and meeting with senior management. Or Medical Fair India 2010. Evening: Check-out of the hotel or remain in Mumbai for Medical Fair India. Depart for Mumbai International airport for onward travel. Participation Requirements All parties interested in participating in the Medical Trade Mission to India must complete and submit an application for consideration by the Department of Commerce. All applicants will be evaluated on their ability to meet certain conditions and best satisfy the selection criteria as outlined below. The mission is open on a first come first served basis to 15 qualified U.S. companies. Additional applications will be considered as time and space permits. Fees and Expenses pwalker on DSK8KYBLC1PROD with NOTICES After a company has been selected to participate on the mission, a payment to the Department of Commerce in the form of a participation fee is required. The participation fees reflect two options: Option 1: March 8–13, 2010. Participation in the Trade Mission in all three cities: New Delhi, Chennai, and Mumbai. The participation fee will be $4,600 for large firms and $3,900 for a small or medium-sized enterprise (SME) 1, this includes one principal representative. The fee for each additional firm representative (large firm or SME) is $500. Option 2: March 8–11, 2010 participate in the Trade Mission in two cities: New Delhi and Chennai and March 12–14, exhibit at the Medical Fair India 2010 in Mumbai. The participation fee for New Delhi-Chennai and exhibiting in the Fair in Mumbai $6,800 ($3,600 Trade Mission fee + $3,200 for 9 square meter booth space 2) for large firms and $ 6,100 ($2,900 Trade Mission fee + $3,200 for 9 square meter booth space) for an SME, which includes one principal representative. The fee for each additional firm 1 An SME is defined as a firm with 500 or fewer employees or that otherwise qualifies as a small business under SBA regulations (see https:// www.sba.gov/services/contracting_opportunities/ sizestandardstopics/). Parent companies, affiliates, and subsidiaries will be considered when determining business size. The dual pricing schedule reflects the Commercial Service’s user fee schedule that became effective May 1, 2008 (for additional information see https://www.export.gov/ newsletter/march2008/initiatives.html). 2 Minimum booth space is 9 square meters. Companies can take larger space for which cost will be calculated accordingly. VerDate Nov<24>2008 1031 16:14 Jan 07, 2010 Jkt 220001 representative (large firm or SME) is $250. Expenses for lodging, some meals, incidentals, and travel (except for transportation to and from meetings) will be the responsibility of each mission participant. Conditions for Participation • An applicant must submit a completed and signed mission application and supplemental application materials, including adequate information on the company’s products and/or services, primary market objectives, and goals for participation. • Each applicant must also certify that the products and services it seeks to export through the mission are either produced in the United States, or, if not, marketed under the name of a U.S. firm and have at least fifty-one percent U.S. content. Selection Criteria for Participation Selection will be based on the following criteria: • Suitability of a company’s products or services to the mission’s goals. • Applicant’s potential for business in India, including likelihood of exports resulting from the trade mission. • Consistency of the applicant’s goals and objectives with the stated scope of the trade mission. Any partisan political activities (including political contributions) of an applicant are entirely irrelevant to the selection process. Timeframe for Recruitment and Applications Mission recruitment will be conducted in an open and public manner, including posting in the Federal Register, the Commerce Department trade mission calendar (https://www.ita.doc.gov/doctm/ tmcal.html), and other Internet Web sites; press releases to general and trade media; direct mail; notices by industry trade associations and other multiplier groups; and publicity at industry meetings, symposia, conferences, and trade shows. Recruitment for the mission will begin immediately and conclude no later than January 31, 2010. PO 00000 Frm 00006 Fmt 4703 Sfmt 4703 Contacts U.S. Commercial Service Healthcare Team: Ms. Jetta DeNend, International Trade Specialist, U.S. Commercial Service, 33 Whitehall St. 22nd Floor, New York, NY 10004, Ph: 212–809– 2644/Fax: 212–809–268, E-mail: Jetta.DeNend@mail.doc.gov. U.S. Commercial Service in India: Mr. Srimoti Mukherji, U.S. Commercial Service, New Delhi, Ph: 91–11– 23472000, ext 2226, Fax: 91–11–2331 5172, Srimoti.Mukherji@mail.doc.gov. Lisa Huot, Global Trade Programs, Commercial Service Trade Missions Program. [FR Doc. 2010–108 Filed 1–7–10; 8:45 am] BILLING CODE P DEPARTMENT OF COMMERCE International Trade Administration (A–533–820) Certain Hot–Rolled Carbon Steel Flat Products from India: Notice of Preliminary Results of Antidumping Duty Administrative Review, and Intent to Rescind in Part AGENCY: Import Administration, International Trade Administration, Department of Commerce. SUMMARY: In response to requests from petitioners,1 the Department of Commerce (‘‘the Department’’) is conducting an administrative review of the antidumping order on certain hot– rolled carbon steel flat products from India (‘‘Indian Hot–Rolled’’) manufactured by Essar Steel Limited (‘‘Essar’’), Ispat Industries Limited (‘‘Ispat’’), JSW Steel Limited (‘‘JSW’’), and Tata Steel Limited (‘‘Tata’’). The period of review (‘‘POR’’) covers December 1, 2007, through November 30, 2008. We preliminarily determine to calculate an antidumping duty margin based upon the application of adverse facts available (‘‘AFA’’) with respect to Essar’s sales. We also preliminarily determine that Ispat, JSW and Tata had no entries of subject merchandise subject to review under this antidumping order during 1 The petitioners are the United States Steel Corporation Steel, Nucor Corporation, and ArcelorMittal USA Inc. (collectively ‘‘petitioners’’). E:\FR\FM\08JAN1.SGM 08JAN1

Agencies

[Federal Register Volume 75, Number 5 (Friday, January 8, 2010)]
[Notices]
[Pages 1029-1031]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-108]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE


International Trade Administration

AGENCY: Department of Commerce.

ACTION: Notice.

-----------------------------------------------------------------------

Mission Statement

    Medical Trade Mission to India: March 8-13, 2010.

Mission Description

    The United States Department of Commerce, International Trade 
Administration, U.S. and Foreign Commercial Service is organizing a 
Medical Trade Mission to New Delhi, Chennai and Mumbai, India, March 8-
13, 2010. The Medical Trade Mission to India will include 
representatives of U.S. medical/healthcare industry manufacturers 
(equipment and devices including laboratory, emergency, diagnostic, 
physiotherapy, and orthopedic equipment, and healthcare information 
technology) and service providers. The mission will introduce U.S. 
suppliers to prospective end-users and partners whose needs and 
capabilities are targeted to each U.S. participant's business 
objectives. The delegates will meet with Indian government officials to 
obtain first-hand information about regulations, policies and 
procedures and will visit healthcare facilities. The Commercial Service 
in India (CS India) will organize appointments and briefings in New 
Delhi, Chennai and Mumbai, India's major healthcare industry hubs. U.S. 
participants will have the opportunity to interact with U.S. Embassy 
and Consulate officials and CS India healthcare specialists to discuss 
industry developments, opportunities, and marketing strategies.
    Medical Fair India, one of the largest medical tradeshows in India, 
coincides in time and location with the last stop of the Trade Mission. 
Trade Mission participants, therefore, can exhibit at the

[[Page 1030]]

tradeshow, in the U.S. Pavilion, as part of their program. Companies 
wishing to exhibit in the U.S. pavilion at the Medical Fair can 
register through the CS India office to receive a discount.

Commercial Setting

    The Indian healthcare industry is experiencing a rapid 
transformation and is emerging as a promising market for U.S. suppliers 
of high-end products. The Indian healthcare market, currently at $35 
billion annually, is expected to reach more than $75 billion annually 
by 2012. The growth in affluence of more than 300 million middle-income 
consumers is creating demand for higher standards of healthcare. The 
changing demographic profile and the rise of lifestyle-related diseases 
have altered the health seeking behavior of the consumer. While private 
insurance covers only 10% of the populations, coverage is growing at 
40% per year.
    The medical infrastructure in India is insufficient for the 
population, with demand for hospitals and beds far exceeding supply. 
The problem is acute in rural India, which accounts for over half of 
India's population, while about 80 percent of available hospital beds 
are located in the urban centers. Both government and private operators 
have major expansion plans to meet demand and increase quality. 
Healthcare in India is provided through primary care facilities and 
secondary and tertiary care hospitals. While the public sector provides 
primary and secondary care, tertiary care hospitals are owned and 
managed by both government and private sector. Over the next 5-6 years, 
150-200 tertiary hospital projects are expected to be constructed, 
including hospitals of varying capacities. Most Indian healthcare 
facilities use imported medical equipment for diagnosis, treatment and 
surgery with over 35% of the imports coming from the U.S. New specialty 
and super-specialty hospitals depend on the import of high-end medical 
equipment for over 65 percent of their needs, and this sector is 
growing at a rate of 15 percent annually.
    Medical tourism is one of the major external drivers of growth in 
India's healthcare sector. India treated 450,000 foreign patients in 
2007 and the expected increase in this sector is contributing to 
improved quality controls. India's National Accreditation Board for 
Hospitals (NABH) operates accreditation programs for healthcare 
organizations. Some private hospitals are also applying for 
certification from international accreditation organizations such as 
the Joint Commission International (JCI). Accreditation by NABH and JCI 
has ensured better standards of healthcare in hospitals.

Mission Goals

    The goal of the Medical Trade Mission to India is to (1) 
familiarize the U.S. companies with the current healthcare situation as 
well as the developments taking place; (2) introduce U.S. companies to 
appropriate government officials in India to learn about various 
regulatory procedures and policies; and (3) introduce companies to 
potential end-users, representatives and partners.

Mission Scenario

    The first stop on the mission itinerary is New Delhi, the capital. 
In meetings with representatives of the Ministry of Health, Drug 
Controller General Office, and Department of Pharmaceuticals, the U.S. 
mission members will learn about policies, regulations and 
opportunities in the country's healthcare industry, such as expansion 
plans of the Fortis and Max hospital groups.
    Chennai and Mumbai are the second and third stops of the mission, 
located in southern and western India respectively. Several corporate 
hospital chains have their headquarters in these cities. These include 
the Apollo Group in Chennai, and Wockhard and the Tata Institute of 
Fundamental Research in Mumbai.
    The three cities on the mission itinerary are the regional hubs for 
the Indian medical/healthcare industry. End-users often prefer to be 
serviced by regional distributors/agents based in these cities, rather 
than country-wide distributors. In all three cities the delegates will 
attend U.S. Embassy or Consulate industry briefings and take part in 
networking events and business matchmaking appointments.

Participation in the mission will include the following:

     Pre-travel briefings/webinars on subjects including 
business practices in India and specifics on the medical/healthcare 
industry;
     Embassy/Consulate briefings on the business climate, 
political scenario, and medical/healthcare industry in New Delhi, 
Chennai and Mumbai;
     Pre-scheduled meetings with potential partners, 
distributors, end-users, or local industry contacts in New Delhi, 
Chennai and Mumbai;
     Meetings with Indian Government officials;
     Tour of public and private hospitals and interaction with 
senior hospital staff;
     Networking receptions in three cities of the trade 
mission;
     Built-up 9sq meter exhibitor booth * in the U.S. Pavilion 
at Medical Fair India, Mumbai. (Option two only.) * Contact us for 
price of booth.

Proposed Mission Timetable

    Mission participants will be encouraged to arrive Saturday, March 
6, 2010 to allow time to adjust to their new surroundings before the 
mission program begins on Monday, March 8.

----------------------------------------------------------------------------------------------------------------
 
----------------------------------------------------------------------------------------------------------------
Monday, March 8.....................................  New Delhi
                                                      Embassy briefing by U.S. Departments of Commerce and State
                                                       Meetings with Government of India ministries.
                                                      One-on-one business appointments.
                                                      Evening: Networking reception.
Tuesday, March 9....................................  New Delhi/Chennai
                                                      Industry briefing.
                                                      One-on-one business appointments.
                                                      Hospital or other site visit.
                                                      Check-out of the hotel.
                                                      Evening flight to Chennai.
Wednesday, March 10.................................  Chennai
                                                      Breakfast briefing by the U.S. Commercial Service at
                                                       hotel.
                                                      Hospital visit and meeting with senior management,
                                                       including the procurement executives.
                                                      One-on-one business appointments.
                                                      Evening: Networking reception.
Thursday, March 11..................................  Chennai/Mumbai
                                                      One-on-one business appointments.
                                                      Check-out of the hotel.
                                                      Afternoon flight to Mumbai.
Friday, March 12....................................  Mumbai

[[Page 1031]]

 
                                                      Breakfast briefing by the U.S. Commercial Service at
                                                       hotel.
                                                      One-on-one business appointments or exhibition at Medical
                                                       Fair India.
                                                      Evening: Networking reception.
Saturday, March 13..................................  Mumbai
                                                      Hospital chain visit and meeting with senior management.
                                                      Or Medical Fair India 2010.
                                                      Evening: Check-out of the hotel or remain in Mumbai for
                                                       Medical Fair India.
                                                      Depart for Mumbai International airport for onward travel.
----------------------------------------------------------------------------------------------------------------

Participation Requirements

    All parties interested in participating in the Medical Trade 
Mission to India must complete and submit an application for 
consideration by the Department of Commerce. All applicants will be 
evaluated on their ability to meet certain conditions and best satisfy 
the selection criteria as outlined below. The mission is open on a 
first come first served basis to 15 qualified U.S. companies. 
Additional applications will be considered as time and space permits.

Fees and Expenses

    After a company has been selected to participate on the mission, a 
payment to the Department of Commerce in the form of a participation 
fee is required. The participation fees reflect two options:
    Option 1: March 8-13, 2010. Participation in the Trade Mission in 
all three cities: New Delhi, Chennai, and Mumbai. The participation fee 
will be $4,600 for large firms and $3,900 for a small or medium-sized 
enterprise (SME) \1\, this includes one principal representative. The 
fee for each additional firm representative (large firm or SME) is 
$500.
---------------------------------------------------------------------------

    \1\ An SME is defined as a firm with 500 or fewer employees or 
that otherwise qualifies as a small business under SBA regulations 
(see https://www.sba.gov/services/contracting_opportunities/sizestandardstopics/). Parent companies, affiliates, and 
subsidiaries will be considered when determining business size. The 
dual pricing schedule reflects the Commercial Service's user fee 
schedule that became effective May 1, 2008 (for additional 
information see https://www.export.gov/newsletter/march2008/initiatives.html).
---------------------------------------------------------------------------

    Option 2: March 8-11, 2010 participate in the Trade Mission in two 
cities: New Delhi and Chennai and March 12-14, exhibit at the Medical 
Fair India 2010 in Mumbai. The participation fee for New Delhi-Chennai 
and exhibiting in the Fair in Mumbai $6,800 ($3,600 Trade Mission fee + 
$3,200 for 9 square meter booth space \2\) for large firms and $ 6,100 
($2,900 Trade Mission fee + $3,200 for 9 square meter booth space) for 
an SME, which includes one principal representative. The fee for each 
additional firm representative (large firm or SME) is $250.
---------------------------------------------------------------------------

    \2\ Minimum booth space is 9 square meters. Companies can take 
larger space for which cost will be calculated accordingly.
---------------------------------------------------------------------------

    Expenses for lodging, some meals, incidentals, and travel (except 
for transportation to and from meetings) will be the responsibility of 
each mission participant.

Conditions for Participation

     An applicant must submit a completed and signed mission 
application and supplemental application materials, including adequate 
information on the company's products and/or services, primary market 
objectives, and goals for participation.
     Each applicant must also certify that the products and 
services it seeks to export through the mission are either produced in 
the United States, or, if not, marketed under the name of a U.S. firm 
and have at least fifty-one percent U.S. content.

Selection Criteria for Participation

    Selection will be based on the following criteria:
     Suitability of a company's products or services to the 
mission's goals.
     Applicant's potential for business in India, including 
likelihood of exports resulting from the trade mission.
     Consistency of the applicant's goals and objectives with 
the stated scope of the trade mission.

Any partisan political activities (including political contributions) 
of an applicant are entirely irrelevant to the selection process.

Timeframe for Recruitment and Applications

    Mission recruitment will be conducted in an open and public manner, 
including posting in the Federal Register, the Commerce Department 
trade mission calendar (https://www.ita.doc.gov/doctm/tmcal.html), and 
other Internet Web sites; press releases to general and trade media; 
direct mail; notices by industry trade associations and other 
multiplier groups; and publicity at industry meetings, symposia, 
conferences, and trade shows. Recruitment for the mission will begin 
immediately and conclude no later than January 31, 2010.

Contacts

    U.S. Commercial Service Healthcare Team: Ms. Jetta DeNend, 
International Trade Specialist, U.S. Commercial Service, 33 Whitehall 
St. 22nd Floor, New York, NY 10004, Ph: 212-809-2644/Fax: 212-809-268, 
E-mail: Jetta.DeNend@mail.doc.gov.
    U.S. Commercial Service in India: Mr. Srimoti Mukherji, U.S. 
Commercial Service, New Delhi, Ph: 91-11-23472000, ext 2226, Fax: 91-
11-2331 5172, Srimoti.Mukherji@mail.doc.gov.

Lisa Huot,
Global Trade Programs, Commercial Service Trade Missions Program.
[FR Doc. 2010-108 Filed 1-7-10; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.